As part of our commitment to fostering a culture of knowledge-sharing and lifelong learning within the African drug discovery community, we are proud to present regular live webinars featuring cutting-edge research by scientists from across the globe.
If you missed any of the recent presentations, you can catch up with recordings on our YouTube page. Here is a quick overview of the topics covered in the first quarter of 2025:
A Scientist’s Guide to Scientific Communication: Skills and Strategies, Tips and Tricks
Presented by John Woodland, a research officer at the University of Cape Town (UCT)’s Holistic Drug Discovery and Development (H3D) Centre, this webinar offers an invaluable toolkit for scientists who want to share their work with a wider audience, but aren’t sure where to start the process.
Watch here
In Silico Approaches to Drug Design
Prof Grace Mugumbate, Pro Vice-Chancellor for Research, Innovation, and Industrialisation at Midlands State University in Zimbabwe shares her expertise in computer-aided drug discovery and development. Her work primarily focuses on finding new drugs for malaria, tuberculosis (TB), and breast cancer and these projects have attracted grants both locally and internationally, underscoring her accomplishments in health research.
Watch here
New Medicines for Malaria control and elimination
Malaria control and elimination is a topic close to the hearts of many of us in the African drug discovery community. In this webinar, Dr Tim Wells, CSO at Medicines for Malaria Venture (MMV) shared some of the latest research in the field.
Watch here.
Lesion-centric pharmacokinetic (PK) & pharmacodynamic (PD) considerations for TB drug discovery and regimen design
As with malaria, tuberculosis (TB) remains a priority for drug discovery research on the African continent. Jansy Sarathy, Assistant Professor at the Hackensack Meridian School of Medicine in Nutley, New Jersey, and Assistant Member at the Center for Discovery and Innovation delivered an engaging presentation on applying site-of-disease pharmacokinetic-pharmacodynamic (PK-PD) concepts to rationalise TB treatment efficacy.
Development of Probiotics and Live Biotherapeutic Products (LBPs) to Support Infant and Women’s Health
This webinar provided fascinating insight into research conducted by Dr Cecile Vernochet, Discovery Project Lead at Gates Medical Research Institute, around scientific discoveries, program development and clinical trials for probiotic nutritional supplements in LMICs.
Watch here.
If you haven’t yet, we invite you to join us for these thought-provoking and inspiring discussions. Keep an eye on our social media profiles and be sure to join our mailing list for regular updates.
Recent Comments